Nanomedicine and Medicinal Plants: Emerging Symbiosis in Managing Lung Diseases and Associated Infections

Overview

Journal EXCLI J

Specialty Biology

Date 2022 Dec 9

PMID 36483911

Authors

Keshav Raj Paudel

Gabriele De Rubis

Nisha Panth

Sachin Kumar Singh

Dinesh Kumar Chellappan

Philip Michael Hansbro

Kamal Dua

Affiliations

Soon will be listed here.

Citing Articles

Fisetin-loaded nanoemulsion ameliorates lung cancer pathogenesis via downregulating cathepsin-B, galectin-3 and enolase in an setting.

Saeid A, Paudel K, De Rubis G, Mehndiratta S, Kokkinis S, Vishwas S EXCLI J. 2024; 23:1238-1244.

PMID: 39574963 PMC: 11579513. DOI: 10.17179/excli2024-7583.

Exploring Bioactive Phytomedicines for Advancing Pulmonary Infection Management: Insights and Future Prospects.

Ho J, Ping T, Paudel K, El Sherkawi T, De Rubis G, Yeung S Phytother Res. 2024; 38(12):5840-5872.

PMID: 39385504 PMC: 11634825. DOI: 10.1002/ptr.8334.

Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease.

De Rubis G, Paudel K, Corrie L, Mehndiratta S, Patel V, Kumbhar P Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(5):2793-2833.

PMID: 37991539 DOI: 10.1007/s00210-023-02830-w.

Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro.

Manandhar B, Paudel K, Clarence D, De Rubis G, Madheswaran T, Panneerselvam J Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(1):343-356.

PMID: 37439806 PMC: 10771618. DOI: 10.1007/s00210-023-02603-5.

References

Wadhwa R, Paudel K, Chin L, Hon C, Madheswaran T, Gupta G . Anti-inflammatory and anticancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro. J Food Biochem. 2020; 45(1):e13572. DOI: 10.1111/jfbc.13572. View

Chan Y, Mehta M, Paudel K, Madheswaran T, Panneerselvam J, Gupta G . Versatility of liquid crystalline nanoparticles in inflammatory lung diseases. Nanomedicine (Lond). 2021; 16(18):1545-1548. DOI: 10.2217/nnm-2021-0114. View

Devkota H, Paudel K, Jha N, Gupta P, Singh S, Chellappan D . Applications of drug-delivery systems targeting inflammasomes in pulmonary diseases. Nanomedicine (Lond). 2021; 16(27):2407-2410. DOI: 10.2217/nnm-2021-0275. View

Wang P, Zhang L, Peng H, Li Y, Xiong J, Xu Z . The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo. Mater Sci Eng C Mater Biol Appl. 2013; 33(8):4802-8. DOI: 10.1016/j.msec.2013.07.047. View

Yen F, Tsai M, Yang C, Liang C, Lin C, Chiang Y . Curcumin nanoparticles ameliorate ICAM-1 expression in TNF-α-treated lung epithelial cells through p47 (phox) and MAPKs/AP-1 pathways. PLoS One. 2013; 8(5):e63845. PMC: 3650060. DOI: 10.1371/journal.pone.0063845. View

Dhanjal D, Sharma P, Mehta M, Tambuwala M, Prasher P, Paudel K . Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases. Future Med Chem. 2022; 14(4):271-288. PMC: 8890134. DOI: 10.4155/fmc-2021-0081. View

Vijayakurup V, Thulasidasan A, G M, Retnakumari A, Nandan C, Somaraj J . Chitosan Encapsulation Enhances the Bioavailability and Tissue Retention of Curcumin and Improves its Efficacy in Preventing B[a]P-induced Lung Carcinogenesis. Cancer Prev Res (Phila). 2019; 12(4):225-236. DOI: 10.1158/1940-6207.CAPR-18-0437. View

Paudel K, Jha S, Rama Raju Allam V, Prasher P, Gupta P, Bhattacharjee R . Recent Advances in Chronotherapy Targeting Respiratory Diseases. Pharmaceutics. 2021; 13(12). PMC: 8704788. DOI: 10.3390/pharmaceutics13122008. View

Solanki N, Mehta M, Chellappan D, Gupta G, Hansbro N, Tambuwala M . Antiproliferative effects of boswellic acid-loaded chitosan nanoparticles on human lung cancer cell line A549. Future Med Chem. 2020; 12(22):2019-2034. DOI: 10.4155/fmc-2020-0083. View

10.

Mehta M, Paudel K, Shukla S, Rama Raju Allam V, Kannaujiya V, Panth N . Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases. J Control Release. 2021; 337:629-644. DOI: 10.1016/j.jconrel.2021.08.010. View

11.

Chan Y, Rama Raju Allam V, Paudel K, Singh S, Gulati M, Dhanasekaran M . Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases. Crit Rev Food Sci Nutr. 2021; 63(19):3302-3332. DOI: 10.1080/10408398.2021.1986467. View

12.

de Oliveira M, Coutinho D, de Souza E, Guterres S, Pohlmann A, Silva P . Orally delivered resveratrol-loaded lipid-core nanocapsules ameliorate LPS-induced acute lung injury via the ERK and PI3K/Akt pathways. Int J Nanomedicine. 2019; 14:5215-5228. PMC: 6636190. DOI: 10.2147/IJN.S200666. View

13.

Prasher P, Sharma M, Mehta M, Paudel K, Satija S, Chellappan D . Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective. Chem Biol Interact. 2020; 325:109125. PMC: 7196551. DOI: 10.1016/j.cbi.2020.109125. View

14.

Wen Z, Jie J, Zhang Y, Liu H, Peng L . A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer. Biochem Biophys Res Commun. 2017; 493(4):1430-1437. DOI: 10.1016/j.bbrc.2017.09.132. View

15.

Manandhar B, Paudel K, Panth N, Hansbro P, Oliver B, Dua K . Applications of extracellular vesicles as a drug-delivery system for chronic respiratory diseases. Nanomedicine (Lond). 2022; 17(12):817-820. DOI: 10.2217/nnm-2021-0384. View

16.

Wang W, Zhu R, Xie Q, Li A, Xiao Y, Li K . Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int J Nanomedicine. 2012; 7:3667-77. PMC: 3414206. DOI: 10.2147/IJN.S30428. View

17.

Chin L, Hon C, Chellappan D, Chellian J, Madheswaran T, Zeeshan F . Molecular mechanisms of action of naringenin in chronic airway diseases. Eur J Pharmacol. 2020; 879:173139. DOI: 10.1016/j.ejphar.2020.173139. View

18.

Paudel K, Wadhwa R, Tew X, Lau N, Madheswaran T, Panneerselvam J . Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro. Life Sci. 2021; 276:119436. DOI: 10.1016/j.lfs.2021.119436. View

19.

Rodenak-Kladniew B, Scioli Montoto S, Sbaraglini M, Di Ianni M, Ruiz M, Talevi A . Hybrid Ofloxacin/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties. Int J Pharm. 2019; 569:118575. DOI: 10.1016/j.ijpharm.2019.118575. View

20.

Mehta M, Malyla V, Paudel K, Chellappan D, Hansbro P, Oliver B . Berberine loaded liquid crystalline nanostructure inhibits cancer progression in adenocarcinomic human alveolar basal epithelial cells in vitro. J Food Biochem. 2021; 45(11):e13954. DOI: 10.1111/jfbc.13954. View